Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more?

Alexander ES, Machan JT, Ng T, Breen LD, DiPetrillo TA, Dupuy DE.

J Vasc Interv Radiol. 2013 Apr;24(4):476-82. doi: 10.1016/j.jvir.2012.12.016. Epub 2013 Feb 23.

PMID:
23462066
2.

An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.

Kwan SW, Mortell KE, Hippe DS, Brunner MC.

J Vasc Interv Radiol. 2014 Oct;25(10):1558-64; quiz 1565. doi: 10.1016/j.jvir.2014.07.002. Epub 2014 Aug 15.

PMID:
25130308
3.

A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.

Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, Robinson C, Patterson GA, Kreisel D, Krupnick AS, Meyers BF.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):428-36. doi: 10.1016/j.jtcvs.2011.10.078. Epub 2011 Dec 9.

4.

Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.

Kwan SW, Mortell KE, Talenfeld AD, Brunner MC.

J Vasc Interv Radiol. 2014 Jan;25(1):1-9.e1. doi: 10.1016/j.jvir.2013.10.018.

PMID:
24365502
5.

Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW.

Radiology. 2007 Apr;243(1):268-75.

PMID:
17392258
6.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.

Carr SR, Schuchert MJ, Pennathur A, Wilson DO, Siegfried JM, Luketich JD, Landreneau RJ.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):390-7. doi: 10.1016/j.jtcvs.2011.10.023. Epub 2011 Dec 9.

7.

Early and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study.

Dell'Amore A, Monteverde M, Martucci N, Sanna S, Caroli G, Stella F, Dell'Amore D, Rocco G.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):250-6. doi: 10.1093/icvts/ivs473. Epub 2012 Nov 23.

8.

Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.

Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE, Schuchert MJ, Gilbert S, Christie NA, Landreneau RJ.

J Thorac Cardiovasc Surg. 2007 Oct;134(4):857-64. Epub 2007 Aug 29.

9.

Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.

Simon TG, Beland MD, Machan JT, Dipetrillo T, Dupuy DE.

Eur J Radiol. 2012 Dec;81(12):4167-72. doi: 10.1016/j.ejrad.2012.06.007. Epub 2012 Jul 24.

PMID:
22835876
10.

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.

Kim AW, Detterbeck FC, Boffa DJ, Decker RH, Soulos PR, Cramer LD, Gross CP.

Ann Thorac Surg. 2012 Sep;94(3):895-901. doi: 10.1016/j.athoracsur.2012.04.091. Epub 2012 Jul 25.

11.

Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.

Shah A, Hahn SM, Stetson RL, Friedberg JS, Pechet TT, Sher DJ.

Cancer. 2013 Sep 1;119(17):3123-32. doi: 10.1002/cncr.28131. Epub 2013 May 29.

12.

Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.

Gunluoglu MZ, Demir A, Turna A, Sansar D, Melek H, Dincer SI, Gurses A.

Ann Thorac Cardiovasc Surg. 2011;17(3):229-35.

PMID:
21697782
13.

Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer.

Ng T, Ryder BA, Chern H, Sellke FW, Machan JT, Harrington DT, Cioffi WG.

J Thorac Cardiovasc Surg. 2012 Apr;143(4):815-9. doi: 10.1016/j.jtcvs.2011.12.031. Epub 2012 Feb 9.

14.

Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.

Ambrogi MC, Fanucchi O, Dini P, Melfi F, Davini F, Lucchi M, Massimetti G, Mussi A.

Eur Respir J. 2015 Apr;45(4):1089-97. doi: 10.1183/09031936.00188014. Epub 2015 Feb 19.

15.

Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.

Zemlyak A, Moore WH, Bilfinger TV.

J Am Coll Surg. 2010 Jul;211(1):68-72. doi: 10.1016/j.jamcollsurg.2010.03.020. Epub 2010 May 26.

PMID:
20610251
16.

Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer.

Hiraki T, Gobara H, Mimura H, Matsui Y, Toyooka S, Kanazawa S.

J Thorac Cardiovasc Surg. 2011 Jul;142(1):24-30. doi: 10.1016/j.jtcvs.2011.02.036. Epub 2011 Apr 29.

17.

Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.

Park BJ, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Da Silva RK, Veronesi G.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):383-9. doi: 10.1016/j.jtcvs.2011.10.055. Epub 2011 Nov 20.

19.

Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer.

Moroga T, Yamashita S, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, Kawahara K.

Ann Thorac Cardiovasc Surg. 2012;18(2):89-94. Epub 2011 Nov 15.

20.

Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.

Sato T, Watanabe A, Kondo H, Kanzaki M, Okubo K, Yokoi K, Matsumoto K, Marutsuka T, Shinohara H, Teramukai S, Kishi K, Ebina M, Sugiyama Y, Meinoshin O, Date H; Japanese Association for Chest Surgery.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):64-9, 70.e1-2. doi: 10.1016/j.jtcvs.2014.08.086. Epub 2014 Sep 18.

Supplemental Content

Support Center